Concepedia

Arnab Basu

AB

14

Publications

401

Citations

12

H-Index

2018

Active since

Affiliations

University of Alabama at Birmingham(Current)

Cleveland Clinic

Emory University

University of Southern California

Rush University Medical Center

Arnab Basu is an author at University of Alabama at Birmingham specializing in medicine, urology, and oncology.

ORCID

Top concepts

Publications per year

2018–2024

14

Publications

14

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Vadim S. Koshkin, Nicholas Henderson, Marihella James et al. · Cancer · 2021 · 80 citations · Full text

Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients

Monica Khunger, Pradnya D. Patil, Arjun Khunger et al. · PLoS ONE · 2018 · 68 citations · Full text

Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study

Toni K. Choueiri, Laurence Albigès, Philippe Barthélémy et al. · The Lancet · 2024 · 54 citations · Full text

, , +8

Association of PD-L1, PD-L2, and Immune Response Markers in Matched Renal Clear Cell Carcinoma Primary and Metastatic Tissue Specimens

Arnab Basu, Jennifer H. Yearley, Lakshmanan Annamalai et al. · American Journal of Clinical Pathology · 2018 · 29 citations

Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma

Patrick L. Sweeney, Yash Suri, Arnab Basu et al. · Cancer Drug Resistance · 2023 · 26 citations · Full text

, , +11

Rows per page

1–5 of 14